, Tracking Stock Market Picks
Enter Symbol:
Anadys Pharmaceuticals, Inc. (ANDS) [hlAlert]

Mkt Perform
down 73.83 %

Anadys Pharmaceuticals, Inc. (ANDS) downgraded to Mkt Perform by Rodman & Renshaw

Posted on: Friday,  Nov 12, 2010  2:25 PM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Perform Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) on 11/12/2010. Previously Rodman & Renshaw rated Mkt Outperform Anadys Pharmaceuticals, Inc. (NASDAQ:
ANDS) on 01/26/2009., when the stock price was $4.74. Since then, Anadys Pharmaceuticals, Inc. has lost 73.84% as of 11/12/2010's recent price of $1.24.
If you would have followed the previous Rodman & Renshaw's recommendation on ANDS, you would have lost 73.83% of your investment in 655 days.

Anadys Pharmaceuticals, Inc., is a biopharmaceutical company committed to advancing patient care by discovering, developing and commercializing novel small molecule medicines for the treatment of viral diseases and cancer. The Company's programs focus on Toll-Like Receptor-based small molecule product candidates and direct antiviral compounds that inhibit key steps in viral proliferation. The Company has core expertise in medicinal chemistry coupled with structure-based drug design, and is developing compounds for the treatment of hepatitis C infection, hepatitis B infection and cancer.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/12/2010 2:25 PM Hold
as of 12/31/2010
1 Week   
1 Month   
3 Months down  -46.55 %
1 YTD down  -41.23 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/26/2009 9:25 AM Buy
4.74 6.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy